Latest Market Data
Refresh
Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

SHANGHAI JUNSHI BIOSCIENCES CO., LTD. - H SHARES (1877)

JUNSHI BIO (1877)

HK$25.900

+0.600 (+2.37%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$25.300
Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$25.600
TURNOVER
HK$87.66M
VOLUME
3.40M
MKT CAP
HK$6.74BH Shares only
LOT SIZE
200
BID
HK$25.900
ASK
HK$25.950
EPS
-
P/E
-
DIV YIELD
-
INTRA-DAY 52W
High HK$26.500 HK$28.800
Low HK$24.800 HK$9.720
Information is available after the market opens and is delayed by at least 15 minutes.
Updated: 25 Jul 2025 10:01 HKT
  • 1 D
  • 1 M
  • 3 M
  • 6 M
  • YTD
  • 1 Y
  • 2 Y
  • 5 Y
  • 10 Y
1min
5min
15min
Hourly
Created with Highstock 6.2.00.00024.50025.00025.50026.00026.5000160K320K10:0011:0012:0013:0014:0015:0016:00Prev. Close
25.300
All charts use the last traded price or closing price.

COMPANY PROFILE

Shanghai Junshi Biosciences Co Ltd is a China-based company mainly engaged in innovation-driven biopharmaceutical business. The Company's main businesses are the discovery, clinical research and development of innovative drugs. The Company's main products include teriprizumab injection, Etesevimab, adalimumab injection and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases and infectious diseases. The Company is also engaged in the clinical research and development of recombinant humanized anti-PCSK9 monoclonal antibody injection and other drugs. The Company provides its products for domestic and overseas markets. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares) 260,295,700 (as at 30 Jun 2025)
Industry Healthcare - Pharmaceuticals & Biotechnology - Biotechnology Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC) Health Care Industry Classification (CSIC) is provided by China Securities Indexes Co., Ltd. and only available for companies dually listed in Hong Kong and Shanghai. Please see the . (CSIC)
Listing Date 24 Dec 2018
Financial Year Ends 31 Dec 2024
Chairman Xiong Jun
Principal Office Room 602
No. 781, Cai Lun Road
China (Shanghai) Pilot
Free Trade Zone, the PRC
Place of Incorporation PRC
Listing Category Primary Listing

a. Updating time-lag
The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.
b. Rights issues or bonus issues
The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.
c. Share splits or share consolidations
The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.
d. Conversion of convertible notes into shares
If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.
Updated: 25 Jul 2025 09:36 HKT
* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced Ex-Date Details Financial Year End Book Close Date Payment date may be indicative only.Payment Date
27 Mar 2025-No Dividend for the period ended
2024/12/31
31 Dec 2024--
30 Aug 2024-No Dividend for the period ended
2024/06/30
31 Dec 2024--
28 Mar 2024-No Dividend for the period ended
2023/12/31
31 Dec 2023--
30 Aug 2023-No Dividend for the period ended
2023/06/30
31 Dec 2023--
30 Mar 2023-No Dividend for the period ended
2022/12/31
31 Dec 2022--
LOAD MORE
Updated: 25 Jul 2025 01:15 HKT
Dividend details are sourced from Announcement Forms published on HKEXnews